[Intranasal vaccine against COVID-19 based on a recombinant variant of the Sendai virus (Paramyxoviridae: Respirovirus ) strain Moscow].

Gleb A Kudrov S S Zainutdinov Antonina A Grazhdantseva A V Shipovalov Galina Sivolobova A V Semenova Iuliia A Merkuleva Dmitriy N Shcherbakov Oleg Svyatoslavovich Taranov Anna Vladimirovna Zaykovskaya I S Shulgina Oleg V Pyankov Galina V Kochneva

Published in: Voprosy virusologii (2023)

Sen-RBDdelta(M) is a promising vaccine construct against SARS-CoV-2 infection and has a protective properties even after a single intranasal introduction.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
cell free